DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹4,543 Cr | ₹5,888 Cr | ₹2,811 Cr | ₹3,570 Cr | ₹2,984 Cr |
What is the latest Cash Flow from Operating Activities ratio of DR REDDYS LABORATORIES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹4,543 Cr |
Mar2023 | ₹5,888 Cr |
Mar2022 | ₹2,811 Cr |
Mar2021 | ₹3,570 Cr |
Mar2020 | ₹2,984 Cr |
How is Cash Flow from Operating Activities of DR REDDYS LABORATORIES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹4,543 Cr | -22.83 | |
Mar2023 | ₹5,888 Cr | 109.46 | |
Mar2022 | ₹2,811 Cr | -21.27 | |
Mar2021 | ₹3,570 Cr | 19.64 | |
Mar2020 | ₹2,984 Cr | - |
Compare Cash Flow from Operating Activities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹99,781.7 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
MANKIND PHARMA | ₹98,888.9 Cr | -4.4% | -7.8% | 13.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -2.1% |
-8.7% |
-2.3% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses